Eli Lilly and Company (LLY) announced the successful completion of its acquisition of Morphic Holding (MORF). Morphic’s common stock will be delisted from The Nasdaq Global Market.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
- Biden administration announces lower prices for 10 Medicare drugs in 2026
- Roche passed on weight-loss pilll now being developed by Eli Lilly, FT says
- U.S. to announce prices for drugs in Medicare negotiations, NY Times says
- LLY, NVO: Which GLP-1 Stock Is the Better Bet?